Fieldpoint Private Securities’s Globus Medical GMED Stock Holding History

Fieldpoint Private Securities’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$4K	Sell	65 -60	-48%	-$3.94K	﹤0.01%	976
2022 Q1	$9K	Buy	125 +15	+14%	+$1.04K	﹤0.01%	1106
2021 Q4	$8K	Buy	110 +30	+38%	+$2.18K	﹤0.01%	1130
2021 Q3	$6K	Hold	80	–	–	﹤0.01%	1205
2021 Q2	$6K	Hold	80	–	–	﹤0.01%	1157
2021 Q1	$5K	Buy	80 +20	+33%	+$1.27K	﹤0.01%	1191
2020 Q4	$4K	Buy	+60	New	+$3.45K	﹤0.01%	1172
2020 Q1	–	Sell	-71	Closed	-$4K	–	366
2019 Q4	$4K	Sell	71 -161	-69%	-$8.74K	﹤0.01%	611
2019 Q3	$12K	Sell	232 -890	-79%	-$42.4K	﹤0.01%	561
2019 Q2	$47K	Buy	+1,122	New	+$48.7K	0.01%	435
2017 Q4	–	Sell	-1,255	Closed	-$37K	–	458
2017 Q3	$37K	Buy	+1,255	New	+$38.3K	0.02%	428

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Fieldpoint Private Securities's GMED Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Globus Medical (GMED) stake by 48% in Q2 2022, selling an estimated $3.94K and leaving 65 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #976.

Fieldpoint Private Securities first reported a position in GMED in Q3 2017 and has held it in 11 quarters since. The position peaked at $47K in Q2 2019. 364 funds tracked by Wall St. Rank hold GMED as of Q2 2022.

Fieldpoint Private Securities held 65 shares of Globus Medical worth $4K as of Q2 2022.
Fieldpoint Private Securities sold 60 Globus Medical shares in Q2 2022, an estimated $3.94K.
Globus Medical made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #976 holding.
Fieldpoint Private Securities first reported a position in Globus Medical in Q3 2017 and has held it in 11 quarters since.
Fieldpoint Private Securities's Globus Medical position peaked at $47K in Q2 2019.
364 funds tracked by Wall St. Rank held Globus Medical as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.